Please login to the form below

Not currently logged in
Email:
Password:

benign prostatic hyperplasia

This page shows the latest benign prostatic hyperplasia news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Sanofi’s all-oral sleeping sickness drug

CHMP backs Sanofi’s all-oral sleeping sickness drug

Italy’s Recordati also got a positive opinion for Silodosin Recordati (siloosin) a generic of its own Urorec drug used to treat benign prostatic hyperplasia (BPH).

Latest news

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Interview: Giovanni Recordati Interview: Giovanni Recordati

    The company also has long expertise in urology. “We are currently rolling out a new drug for the treatment of benign prostatic hyperplasia and will soon be starting the last phase

  • Call to action for BPH

    Campaign:ProState of the Nation. Timescale:February to October 2009. ProState of the Nation is an evidence-based report, bringing the issues of under-management and under-treatment of Benign Prostatic ... Benign Prostatic Hyperplasia (BPH) is a condition

  • Interview: Jorge Gallardo, Almirall Interview: Jorge Gallardo, Almirall

    The year's sales evolution has benefited from the launches of new products Silodyx (for benign prostatic hyperplasia, licence from Recordati) and Conbriza  (for osteoporosis, in co-promotion with Pfizer) in

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....